Xinjie Xu

869 total citations
35 papers, 483 citations indexed

About

Xinjie Xu is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Xinjie Xu has authored 35 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 9 papers in Genetics and 9 papers in Oncology. Recurrent topics in Xinjie Xu's work include Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Xinjie Xu is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Xinjie Xu collaborates with scholars based in United States, China and United Kingdom. Xinjie Xu's co-authors include Yuhua Li, Sanfang Tu, Qihang Sun, Xiaoqian Liang, Xiaoli Zhang, Xuan Zhou, Meifang Li, Zitong Chen, Yu Liu and Huilin Tu and has published in prestigious journals such as Blood, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Xinjie Xu

33 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinjie Xu United States 9 290 160 118 99 96 35 483
Sunil S. Raikar United States 13 405 1.4× 205 1.3× 111 0.9× 252 2.5× 108 1.1× 37 639
Rawan Faramand United States 10 210 0.7× 154 1.0× 59 0.5× 57 0.6× 115 1.2× 37 375
Adam J. Lamble United States 12 282 1.0× 159 1.0× 57 0.5× 147 1.5× 256 2.7× 54 548
Andrea Pepper United Kingdom 8 187 0.6× 121 0.8× 42 0.4× 132 1.3× 96 1.0× 19 348
Axel Hyrenius‐Wittsten Sweden 7 277 1.0× 249 1.6× 70 0.6× 117 1.2× 179 1.9× 11 621
Cuicui Lyu China 11 244 0.8× 159 1.0× 92 0.8× 94 0.9× 71 0.7× 36 443
Frauke M. Schnorfeil Germany 7 371 1.3× 164 1.0× 64 0.5× 282 2.8× 202 2.1× 9 556
Mayumi Sugita United States 12 141 0.5× 193 1.2× 43 0.4× 103 1.0× 240 2.5× 24 482
Marion Alcantara France 9 259 0.9× 103 0.6× 68 0.6× 121 1.2× 16 0.2× 24 402
Shilpa Alekar United States 5 475 1.6× 94 0.6× 45 0.4× 152 1.5× 123 1.3× 5 655

Countries citing papers authored by Xinjie Xu

Since Specialization
Citations

This map shows the geographic impact of Xinjie Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinjie Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinjie Xu more than expected).

Fields of papers citing papers by Xinjie Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinjie Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinjie Xu. The network helps show where Xinjie Xu may publish in the future.

Co-authorship network of co-authors of Xinjie Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinjie Xu. A scholar is included among the top collaborators of Xinjie Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinjie Xu. Xinjie Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, L, Xinjie Xu, & Kaiyang Lv. (2025). DeepSeek-R1 and GPT-4 are comparable in a complex diagnostic challenge: a historical control study. International Journal of Surgery. 111(6). 4056–4059. 3 indexed citations
2.
Huang, Shengkang, Xinyu Wang, Yu Wang, et al.. (2023). Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies. Molecular Cancer. 22(1). 80–80. 25 indexed citations
3.
Xu, Xinjie, et al.. (2022). The Difference of Gut Microbiota and Their Correlations With Urinary Organic Acids Between Autistic Children With and Without Atopic Dermatitis. Frontiers in Cellular and Infection Microbiology. 12. 886196–886196. 5 indexed citations
4.
Smadbeck, James B., George Vasmatzis, Horatiu Olteanu, et al.. (2022). Identification of EWSR1 rearrangements in patients with immature hematopoietic neoplasms: A case series and review of literature. Annals of Diagnostic Pathology. 58. 151942–151942. 1 indexed citations
5.
Xu, Xinjie, et al.. (2021). TP53 Allelic Status in Myeloid Malignancies. Blood. 138(Supplement 1). 4458–4458. 3 indexed citations
6.
Xu, Xinjie, Shengkang Huang, Xinyi Xiao, et al.. (2021). Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments. Frontiers in Immunology. 11. 569117–569117. 39 indexed citations
7.
Guenzel, Adam J., James B. Smadbeck, George Vasmatzis, et al.. (2021). Clinical utility of next generation sequencing to detect IGH/IL3 rearrangements [t(5;14)(q31.1;q32.1)] in B-lymphoblastic leukemia/lymphoma. Annals of Diagnostic Pathology. 53. 151761–151761. 8 indexed citations
8.
McGarrah, Patrick W., Horatiu Olteanu, Daniel L. Van Dyke, et al.. (2021). Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions. Cancer Genetics. 260-261. 1–5. 2 indexed citations
9.
Xu, Xinjie, Christian N. Paxton, Robert J. Hayashi, et al.. (2021). Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma. Blood Advances. 5(14). 2890–2900. 5 indexed citations
10.
Xu, Xinjie, William R. Sukov, Patricia T. Greipp, et al.. (2020). Siblings with ETV6/RUNX1-positive B-lymphoblastic leukemia: A single site experience and review of the literature. Annals of Diagnostic Pathology. 48. 151588–151588. 1 indexed citations
11.
Polonis, Katarzyna, Matthew Schultz, Horatiu Olteanu, et al.. (2020). Detection of cryptic CCND1 rearrangements in mantle cell lymphoma by next generation sequencing. Annals of Diagnostic Pathology. 46. 151533–151533. 7 indexed citations
12.
Blackburn, Patrick R., Linda B. Baughn, Rhett P. Ketterling, et al.. (2020). Identification of a novel KMT2A/GIMAP8 gene fusion in a pediatric patient with acute undifferentiated leukemia. Genes Chromosomes and Cancer. 60(2). 108–111. 4 indexed citations
13.
Blackburn, Patrick R., James B. Smadbeck, Beth A. Pitel, et al.. (2020). Cryptic and atypical KMT2A‐USP2 and KMT2A‐USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia. Genes Chromosomes and Cancer. 59(7). 422–427. 8 indexed citations
14.
Pitel, Beth A., Neeraj Sharma, Cinthya Zepeda‐Mendoza, et al.. (2020). Clinical Value of Next Generation Sequencing in the Detection of Recurring Structural Rearrangements and Copy Number Abnormalities in Acute Myeloid Leukemia. Blood. 136(Supplement 1). 21–22. 1 indexed citations
15.
Xu, Xinjie, Qihang Sun, Xiaoqian Liang, et al.. (2019). Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies. Frontiers in Immunology. 10. 2664–2664. 219 indexed citations
16.
Shen, Wei, Philippe Szankasi, Jacob Durtschi, Todd W. Kelley, & Xinjie Xu. (2019). Genome-Wide Copy Number Variation Detection Using NGS: Data Analysis and Interpretation. Methods in molecular biology. 1908. 113–124. 13 indexed citations
17.
Shen, Wei, Christian N. Paxton, Philippe Szankasi, et al.. (2017). Detection of genome-wide copy number variants in myeloid malignancies using next-generation sequencing. Journal of Clinical Pathology. 71(4). 372–378. 7 indexed citations
18.
Geiersbach, Katherine B., Carlynn Willmore‐Payne, Christian N. Paxton, et al.. (2016). Genomic Copy Number Analysis ofHER2-Equivocal Breast Cancers. American Journal of Clinical Pathology. 146(4). 439–447. 4 indexed citations
19.
Xu, Xinjie & Todd W. Kelley. (2014). The Future is Now for the Laboratory Evaluation of Myelodysplastic Syndromes. The Hematologist. 11(5). 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sunil S. Raikar Breakdown of academic impact, for papers by Rawan Faramand Breakdown of academic impact, for papers by Adam J. Lamble Breakdown of academic impact, for papers by Andrea Pepper Breakdown of academic impact, for papers by Axel Hyrenius‐Wittsten Breakdown of academic impact, for papers by Cuicui Lyu Breakdown of academic impact, for papers by Frauke M. Schnorfeil Breakdown of academic impact, for papers by Mayumi Sugita Breakdown of academic impact, for papers by Marion Alcantara Breakdown of academic impact, for papers by Shilpa Alekar
Rankless by CCL
2026